Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST study

Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST study

Background Methotrexate (MTX) is frequently used in the treatment of moderate-to-severe psoriasis, however, there is limited data on health-related quality-of-life (HRQoL), psoriasis clinical outcomes and hepatic fibrosis in MTX-treated patients in routine clinical practice. Objectives To investigat...

Full description

Bibliographic Details
Main Authors: Raquel Rivera, E. Vilarrasa, M. Ribera, E. Roe, T. Kueder-Pajares, A. I. Zayas, L. Martínez-Molina, J. Mataix Díaz, I. M. Rodríguez-Nevado, T. Usero-Bárcena, D. de la Mano, C. García-Donoso, A. Olveira, G. Guinea, V. Martín-Vázquez, M. Ferran
Format: Article
Language:English
Published: Taylor & Francis Group 2022-04-01
Series:Journal of Dermatological Treatment
Subjects:
health-related quality of life
hepatic fibrosis
hepatic steatosis
methotrexate
psoriasis
spain
Online Access:http://dx.doi.org/10.1080/09546634.2020.1801977

Internet

http://dx.doi.org/10.1080/09546634.2020.1801977

Similar Items